$3.35
-0.25-6.95%
At close: -
$3.41
0.061.94%
After Hours: 6:33 PM EDT
Comments
Loading...
Prime Medicine (PRME) Forecast
NewsEarningsPrime Medicine (PRME) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPrime Medicine (NASDAQ:PRME) Stock Quotes, Forecast and News Summary
Prime Medicine Stock (NASDAQ: PRME) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Prime Medicine (PRME) stock?
You can purchase shares of Prime Medicine (NASDAQ:PRME) through any online brokerage.
Who are Prime Medicine (PRME) competitors?
Other companies in Prime Medicine’s space includes: KalVista Pharma (NASDAQ:KALV), 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR) and Korro Bio (NASDAQ:KRRO).
What is the forecast, or price target, for Prime Medicine (PRME) stock?
Prime Medicine has a consensus price target of $16.92.
What is the current price for Prime Medicine (PRME)?
The stock price for Prime Medicine (NASDAQ: PRME) is $3.41 last updated November 15, 2024 at 6:33 PM EST.
Does Prime Medicine (PRME) pay a dividend?
A quarterly cash dividend of 0.80 per share of Class A Common Stock. The quarterly cash dividend was payable on September 12, 2019 to stockholders of record on September 10, 2019.
When is Prime Medicine (NASDAQ:PRME) reporting earnings?
Prime Medicine’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Prime Medicine (PRME) going to split?
There is no upcoming split for Prime Medicine.
What sector and industry does Prime Medicine (PRME) operate in?
Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.